Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-274.01%EBITDA Margin
VS
Market
Sector
Industry
History
$ 0.7Close
$ 0.18 - $ 1.57 52-Week Range
Ticker Information
Ticker
PSTVCompany Name
PLUS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPLUS THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PSTV - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -14.57M | -274.01% | $ 5.32M |
| 3/31/2025 | $ -18.82M | -361.54% | $ 5.21M |
| 12/31/2024 | $ -8.4M | -144.27% | $ 5.82M |
| 9/30/2024 | $ -8.35M | -145.92% | $ 5.72M |
| 6/30/2024 | $ -8.72M | -158.23% | $ 5.51M |
| 3/31/2024 | $ -10.73M | -176.41% | $ 6.08M |
| 12/31/2023 | $ -12.18M | -247.83% | $ 4.91M |
| 9/30/2023 | $ -13.82M | -368.49% | $ 3.75M |
| 6/30/2023 | $ -15.8M | -611.49% | $ 2.58M |
| 3/31/2023 | $ -19.55M | -2678.77% | $ 730K |
Key Performance Insights, Last 5 Years
- PLUS THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at -144.53%.
- Over the past 5 years, PLUS THERAPEUTICS INC's average EBITDA % has been -2964.62%.
- The median EBITDA % for PLUS THERAPEUTICS INC during this period was -361.54%
- PLUS THERAPEUTICS INC reached its highest EBITDA % over the past 5 years at -144.27%.
- The lowest EBITDA % recorded by PLUS THERAPEUTICS INC in the same timeframe -23909.59%
PLUS THERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for PLUS THERAPEUTICS INC is calculated as follows: EBITDA [ $ -2.15M ] / Revenues [ $ 1.49M ]
(=) EBITDA % [ -144.53% ] PSTV - EBITDA Margin, Last 5 years
-23909.59%
Minimum
Sep 30, 2022
-144.27%
Maximum
Dec 31, 2024
-2964.62%
Average
-361.54%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.33% |
| max | 97.24% |
| average | 16.2% |
| median | 14.74% |
| std | 26.73% |